An immunocytochemical assay to detect human CFTR expression following gene transfer

Molecular and Cellular Probes

Volumn 23, Issue 6, 2009, Pages 272-280

  Davidson, Heather ^a,h   Wilson, Abigail ^a,h   Gray, Robert D ^a,h   Horsley, Alex ^a,h   Pringle, Ian A ^c,h   McLachlan, Gerry ^b,h   Nairn, Angus C ^f,g   Stearns, Cordelia ^f,g   Gibson, James ^a,h   Holder, Emma ^a,h   Jones, Lisa ^a,h   Doherty, Ann ^a,h   Coles, Rebecca ^c,h   Sumner Jones, Stephanie G ^c,h   Wasowicz, Marguerite ^d,h   Manvell, Michelle ^d,h   Griesenbach, Uta ^d,h   Hyde, Stephen C ^c,h   Gill, Deborah R ^c,h   Davies, Jane ^d,e,h   Collie, D David S ^b,h   Alton, Eric W F W ^d,h   Porteous, David J ^a,h   Boyd, A Christopher ^a,h   more..

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

^f ROCKEFELLER UNIVERSITY   (United States)

^g YALE UNIVERSITY   (United States)

^h UK Cystic Fibrosis Gene Therapy Consortium ^*  (United Kingdom)

Author keywords

CFTR antibodies; Cystic fibrosis; Gene transfer; Nasal brushing cells

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; EPITHELIUM CELL; GENE EXPRESSION; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ANTIBODIES; CELLS, CULTURED; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, FLUORESCENCE; NASAL MUCOSA; REPRODUCIBILITY OF RESULTS; RESPIRATORY MUCOSA; TRANSFECTION; TRANSGENES;

EID: 70350617800     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcp.2009.07.001     Document Type: Article

References (35)

1. Rich D.P., Anderson M.P., Gregory R.J., Cheng S.H., Paul S., Jefferson D.M., et al. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 347 (1990) 358-363
2. Sheppard D.N., and Welsh M.J. Structure and function of the CFTR chloride channel. Physiol Rev 79 (1999) S23-S45
3. Engelhardt J.F., Yankaskas J.R., Ernst S.A., Yang Y., Marino C.R., Boucher R.C., et al. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet 2 (1992) 240-248
4. Mehta A. CFTR: more than just a chloride channel. Pediatr Pulmonol 39 (2005) 292-298
5. Schwiebert E.M., Benos D.J., Egan M.E., Stutts M.J., and Guggino W.B. CFTR is a conductance regulator as well as a chloride channel. Physiol Rev 79 (1999) S145-S166
6. Rowntree R.K., and Harris A. The phenotypic consequences of CFTR mutations. Ann Hum Genet 67 (2003) 471-485
7. Pilewski J.M., and Frizzell R.A. Role of CFTR in airway disease. Physiol Rev 79 (1999) S215-S255
8. Cutting G.R. Modifier genetics: cystic fibrosis. Annu Rev Genomics Hum Genet 6 (2005) 237-260
9. Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration 67 (2000) 117-133
10. Chadwick S.L., Kingston H.D., Stern M., Cook R.M., O'Connor B.J., Lukasson M., et al. Safety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to the lungs of normal volunteers. Gene Ther 4 (1997) 937-942
11. Gill D.R., Smyth S.E., Goddard C.A., Pringle I.A., Higgins C.F., Colledge W.H., et al. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Ther 8 (2001) 1539-1546
12. Hyde S.C., Southern K.W., Gileadi U., Fitzjohn E.M., Mofford K.A., Waddell B.E., et al. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther 7 (2000) 1156-1165
13. Porteous D.J., Dorin J.R., McLachlan G., Davidson-Smith H., Davidson H., Stevenson B.J., et al. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther 4 (1997) 210-218
14. Ferrari S., Griesenbach U., Geddes D.M., and Alton E. Immunological hurdles to lung gene therapy. Clin Exp Immunol 132 (2003) 1-8
15. Griesenbach U., and Boyd A.C. Pre-clinical and clinical endpoint assays for cystic fibrosis gene therapy. J Cyst Fibros 4 (2005) 89-100
16. Koehler D.R., Hitt M.M., and Hu J. Challenges and strategies for cystic fibrosis lung gene therapy. Mol Ther 4 (2001) 84-91
17. Montier T., Delepine P., Pichon C., Ferec C., Porteous D.J., and Midoux P. Non-viral vectors in cystic fibrosis gene therapy: progress and challenges. Trends Biotechnol 22 (2004) 586-592
18. Davidson D.J., and Rolfe M. Mouse models of cystic fibrosis. Trends Genet 17 (2001) S29-S37
19. Ramalho A.S., Beck S., Meyer M., Penque D., Cutting G.R., and Amaral M.D. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am J Respir Cell Mol Biol 27 (2002) 619-627
20. Lukacs G.L., Mohamed A., Kartner N., Chang X.B., Riordan J.R., and Grinstein S. Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J 13 (1994) 6076-6086
21. Carvalho-Oliveira I., Efthymiadou A., Malho R., Nogueira P., Tzetis M., Kanavakis E., et al. CFTR localization in native airway cells and cell lines expressing wild-type or F508del-CFTR by a panel of different antibodies. J Histochem Cytochem 52 (2004) 193-203
22. Claass A., Sommer M., de Jonge H., Kalin N., and Tummler B. Applicability of different antibodies for immunohistochemical localization of CFTR in sweat glands from healthy controls and from patients with cystic fibrosis. J Histochem Cytochem 48 (2000) 831-837
23. Kalin N., Claass A., Sommer M., Puchelle E., and Tummler B. DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis. J Clin Invest 103 (1999) 1379-1389
24. Kreda S.M., Mall M., Mengos A., Rochelle L., Yankaskas J., Riordan J.R., et al. Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol Biol Cell 16 (2005) 2154-2167
25. Dormer R.L., McNeilly C.M., Morris M.R., Pereira M.M., Doull I.J., Becq F., et al. Localisation of wild-type and DeltaF508-CFTR in nasal epithelial cells. Pflugers Arch 443 Suppl. 1 (2001) S117-S120
26. Penque D., Mendes F., Beck S., Farinha C., Pacheco P., Nogueira P., et al. Cystic fibrosis F508del patients have apically localized CFTR in a reduced number of airway cells. Lab Invest; J Tech Methods Pathol 80 (2000) 857-868
27. Dupuit F., Kalin N., Brezillon S., Hinnrasky J., Tummler B., and Puchelle E. CFTR and differentiation markers expression in non-CF and delta F 508 homozygous CF nasal epithelium. J Clin Invest 96 (1995) 1601-1611
28. Kartner N., Augustinas O., Jensen T.J., Naismith A.L., and Riordan J.R. Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland. Nat Genet 1 (1992) 321-327
29. Mall M., Kreda S.M., Mengos A., Jensen T.J., Hirtz S., Seydewitz H.H., et al. The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon. Gastroenterology 126 (2004) 32-41
30. Hyde S.C., Pringle I.A., Abdullah S., Lawton A.E., Davies L.A., Varathalingam A., et al. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat Biotechnol 26 (2008) 549-551
31. Davidson H., McLachlan G., Wilson A., Boyd A.C., Doherty A., MacGregor G., et al. Human-specific cystic fibrosis transmembrane conductance regulator antibodies detect in vivo gene transfer to ovine airways. Am J Respir Cell Mol Biol 35 (2006) 72-83
32. Alton E.W., Stern M., Farley R., Jaffe A., Chadwick S.L., Phillips J., et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 353 (1999) 947-954
33. McLachlan G., Baker A., Tennant P., Gordon C., Vrettou C., Renwick L., et al. Optimizing aerosol gene delivery and expression in the ovine lung. Mol Ther 15 (2007) 348-354
34. Rose A.C., Goddard C.A., Colledge W.H., Cheng S.H., Gill D.R., and Hyde S.C. Optimisation of real-time quantitative RT-PCR for the evaluation of non-viral mediated gene transfer to the airways. Gene Ther 9 (2002) 1312-1320
35. Ganeshan R., Nowotarski K., Di A., Nelson D.J., and Kirk K.L. CFTR surface expression and chloride currents are decreased by inhibitors of N-WASP and actin polymerization. Biochim Biophys Acta 1773 (2007) 192-200